ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ

$2.85

$--

(0.00%)

Sonoma Pharmaceuticals, Inc. (SNOA) Live Price Chart

Page last updated: --

Key Market Data

Market Cap	$4.85M
Open	$2.82
High	$1,484.59
Low	$1.75
Previous Close	$2.85
Price Change	--
Percentage Change	0.00%
Volume	35K

Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Today

Sonoma Pharmaceuticals, Inc. (SNOA) is currently trading at $2.85 as of null, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -1,310.98% over the past four weeks. Over the last 12 months, Sonoma Pharmaceuticals, Inc. has recorded a +12.20% price change, indicating a stable performance relative to the broader market.

Sonoma Pharmaceuticals, Inc. (SNOA) 7-Day Stock Price Changes

Over the past seven days, Sonoma Pharmaceuticals, Inc. has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $3.00 to the latest recorded price of $2.85, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (34,537), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, SNOA has delivered a -1,310.98% return over the past month and a +12.20% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy Sonoma Pharmaceuticals, Inc. (SNOA)

You can buy and trade SNOA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for SNOA and Execute Your Trade

Open the trading page, enter SNOA in the search bar, select the amount of SNOA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Sonoma Pharmaceuticals, Inc. (SNOA)?

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Sonoma Pharmaceuticals, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	168
Sector	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website	https://www.sonomapharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Sonoma Pharmaceuticals, Inc.?

The latest trading price for Sonoma Pharmaceuticals, Inc. (Common Stock) is $ 2.85, compared with a previous closing price of $ 2.85. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for SNOA can be tracked on the live chart and quote section on this page.

2.Is Sonoma Pharmaceuticals, Inc. stock going up or down?

Looking at recent performances, SNOA has returned -1,310.98% over the past month, -46.73% over the last six months and +12.20% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Sonoma Pharmaceuticals, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does SNOA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Sonoma Pharmaceuticals, Inc. has traded between a low of $ 1.75 and a high of $ 6.92. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether SNOA is currently nearer the top or the bottom of its one-year trading band.

4.How is Sonoma Pharmaceuticals, Inc. classified by sector and industry?

Sonoma Pharmaceuticals, Inc. is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. In practice, this means Sonoma Pharmaceuticals, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing SNOA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector could influence Sonoma Pharmaceuticals, Inc.’s performance.

5.Where is Sonoma Pharmaceuticals, Inc. listed and how large is it by market value?

Sonoma Pharmaceuticals, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 4.85M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Sonoma Pharmaceuticals, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does SNOA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.98 summarises how much profit Sonoma Pharmaceuticals, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Sonoma Pharmaceuticals, Inc.'s financial performance over time?

To follow Sonoma Pharmaceuticals, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how SNOA is performing and how the market is responding.

8.When is Sonoma Pharmaceuticals, Inc. expected to report earnings?

Sonoma Pharmaceuticals, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for SNOA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Sonoma Pharmaceuticals, Inc.'s earnings reports?

Sonoma Pharmaceuticals, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether SNOA is meeting, beating or missing expectations.

10.How can I stay informed about Sonoma Pharmaceuticals, Inc.'s results and guidance?

You can stay up to date on Sonoma Pharmaceuticals, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for SNOA on this page helps you see how new information is being reflected in the stock.

11.Does Sonoma Pharmaceuticals, Inc. pay a regular cash dividend to its shareholders?

Sonoma Pharmaceuticals, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor SNOA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for SNOA?

Based on the latest earnings data, SNOA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Sonoma Pharmaceuticals, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Sonoma Pharmaceuticals, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Sonoma Pharmaceuticals, Inc.?

Sonoma Pharmaceuticals, Inc. is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is SNOA valued in terms of P/E ratio and EPS?

Sonoma Pharmaceuticals, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.98. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Sonoma Pharmaceuticals, Inc.'s earnings. Comparing SNOA's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Sonoma Pharmaceuticals, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

AGNC Investment Corp.

AGNC

AvePoint, Inc.

AVPT

Bobs Discount Furniture, Inc.

BOBS

Definium Therapeutics, Inc.

DFTX

Reliance Global Group, Inc.

EZRA

Top Gainers

Browse today's leading gainers in the US stock market

Peabody Energy Corporation

BTU

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

SNOA-to-USD Calculator

Amount

SNOA

USD

1 SNOA = 2.85 USD